Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
The primary objective is to collect data on treatment outcomes (clinical and microbiological cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with serious intra-abdominal and hepatobiliary infections in Slovakia.
Drug: CP-75385-02 Cefoperazone/sulbactam
|Study Design:||Time Perspective: Prospective|
|Official Title:||Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections In Slovakia. An Open, Prospective, Non-Comparative Study.|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00463762
|Study Director:||Pfizer CT.gov Call Center||Pfizer|